Disease
-
Asian head and neck cancer patients live longer with immunotherapy than mixed race group
Dec 18, 2016News Hour: Asian head and neck cancer patients live longer with the immunotherapy pembrolizumab than the overall population, according to a sub-analysis of the KEYNOTE-012 trial presented at the ESMO ASIA 2016 Congress in Singapore. Head... -
Almost 20% of breast cancer patients fail to complete prescribed endocrine therapy
Dec 18, 2016News Hour: Around 20% of breast cancer patients do not complete prescribed endocrine therapy, researchers report at the ESMO Asia 2016 Congress in Singapore. The study in over 5,500 women found that younger patients and those who... -
Immunotherapy drug gives non-small-cell lung cancer patients extra four months of life with fewer side effects compared to chemotherapy
Dec 18, 2016News Hour: Patients with advanced non-small-cell lung cancer survive four months longer with fewer side effects on an immunotherapy drug called a tezolizumab compared to chemotherapy, according to a phase 3 clinical trial published in The... -
Novartis’ Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment
Dec 11, 2016News Hour: CRYSTAL was a prospective, multicenter, 12-week, randomized, pragmatic, open-label trial. Patients were recruited into four groups according to previous medication and symptoms, and randomized to a direct switch to Seebri® Breezhaler® (glycopyrronium) 50 mcg... -
All of France placed on ‘high risk’ restrictions over bird flu
Dec 6, 2016News Hour: France widened “high risk” restrictions to the entire country after the detection of several cases of the highly pathogenic H5N8 avian flu strain in farms in southwest France and in wild ducks in northern... -
South Korea expands poultry cull to fight bird flu
Dec 6, 2016News Hour: South Korea plans to cull more chickens and ducks as it tries to contain an outbreak of bird flu, with a total of around 8 percent of the nation’s poultry population expected to be... -
Roche’s Gazyva cancer drug, raises questions
Dec 5, 2016News Hour: Roche’s Gazyva cancer drug did not show a significant overall survival benefit and raised greater safety concerns than its predecessor Rituxan, a study showed, raising doubts over the Swiss pharmaceuticals group’s bid to replace... -
Do you know about kidney disease?
Dec 2, 2016News Hour: The kidneys are bean-shaped organs that serve several essential regulatory roles in vertebrates. Their main function is to regulate the balance of electrolytes in the blood, along with maintaining pH homeostasis. They also remove... -
WHO issues new guidance on HIV self-testing ahead of World AIDS Day
Dec 2, 2016News Hour: According to a new WHO progress report lack of an HIV diagnosis is a major obstacle to implementing the Organization’s recommendation that everyone with HIV should be offered antiretroviral therapy (ART). The report reveals... -
AMG 334 significantly reduces monthly migraine days in second pivotal Phase III episodic migraine study
Nov 17, 2016News Hour: Novartis announced positive topline results from the global Phase III STRIVE study, evaluating the efficacy and safety of the fully human monoclonal antibody AMG 334 (erenumab) in episodic migraine prevention. Once-monthly subcutaneous AMG 334...
